These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 35072932)
1. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria. Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932 [TBL] [Abstract][Full Text] [Related]
2. ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study. Liu C; Li J; Wong YJ; Xie Q; Hirooka M; Enomoto H; Kim TH; Hanafy AS; He R; Koizumi Y; Hiasa Y; Nishimura T; Iijima H; Jung YK; Yim HJ; Ma J; Zeng QL; Sarin SK; Qi X Hepatol Int; 2022 Oct; 16(5):1105-1115. PubMed ID: 35606627 [TBL] [Abstract][Full Text] [Related]
3. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta. Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B J Hepatol; 2024 Aug; 81(2):248-257. PubMed ID: 38479612 [TBL] [Abstract][Full Text] [Related]
4. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Scheiner B; Balcar L; Semmler G; Stättermayer AF; Pinter M; Quehenberger P; Trauner M; Reiberger T; Mandorfer M Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1854-1863.e10. PubMed ID: 36244661 [TBL] [Abstract][Full Text] [Related]
5. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient. Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352 [TBL] [Abstract][Full Text] [Related]
6. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641 [TBL] [Abstract][Full Text] [Related]
7. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China. Liu C; Zhang L; Zhang S; Li X; Wong YJ; Liang X; Wang Y; Wu X; Gou W; Lv J; Hu S; Fu J; Huang J; Ge G; Huang M; Wang F; Zhang Q; Ren T; Meng Z; Ding D; Zhuoga B; Zhuoga C; Fan J; Dang D; Miao L; Song Z; Xiao X; Wu H; Jiang K; Liu T; Gao Y; Ma L; Fang T; Wang Y; Zhang Q; Zhu D; Ji D; Cao Z; Zeng QL; Li J; Chen P; Wei Y; Tong Z; Hong Z; Liang X; Li Y; Nan Y; Qi X BMJ Open; 2024 Jul; 14(7):e081623. PubMed ID: 38991669 [TBL] [Abstract][Full Text] [Related]
9. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352 [TBL] [Abstract][Full Text] [Related]
10. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368 [TBL] [Abstract][Full Text] [Related]
11. An LSM Based Strategy is Comparable to HVPG Measurement to Predict Further Events in Patients with Cirrhosis with Variceal Bleeding as Their Index Decompensation. Sharma S; Agarwal S; Saraya A J Clin Exp Hepatol; 2023; 13(5):774-782. PubMed ID: 37693274 [TBL] [Abstract][Full Text] [Related]
13. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis. Ahmed S; Sharma S; Agarwal S; Wong YJ; Putera M; Saraya A Indian J Gastroenterol; 2024 Jun; 43(3):609-615. PubMed ID: 37840111 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease. Jindal A; Agarwal S; Sharma S; Kumar M; Saraya A; Sarin SK Dig Dis Sci; 2023 May; 68(5):2149-2157. PubMed ID: 36562888 [TBL] [Abstract][Full Text] [Related]
15. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. Zhou H; Long J; Hu H; Tian CY; Lin SD World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876 [TBL] [Abstract][Full Text] [Related]
16. Non-invasive diagnosis and follow-up of portal hypertension. Thabut D; Weil D; Bouzbib C; Rudler M; Cassinotto C; Castéra L; Serste T; Oberti F; Ganne-Carrié N; de Lédinghen V; Bourlière M; Bureau C Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101767. PubMed ID: 34332128 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease. Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942 [TBL] [Abstract][Full Text] [Related]
19. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. Colecchia A; Colli A; Casazza G; Mandolesi D; Schiumerini R; Reggiani LB; Marasco G; Taddia M; Lisotti A; Mazzella G; Di Biase AR; Golfieri R; Pinzani M; Festi D J Hepatol; 2014 Jun; 60(6):1158-64. PubMed ID: 24607624 [TBL] [Abstract][Full Text] [Related]
20. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease. Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]